BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

233 hedge funds and large institutions have $2.09B invested in BioCryst Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 67 increasing their positions, 71 reducing their positions, and 21 closing their positions.

Holders
233
Holders Change
+27
Holders Change %
+13.11%
% of All Funds
3.69%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
50
Increased
67
Reduced
71
Closed
21
Calls
$92M
Puts
$34.8M
Net Calls
+$57.2M
Net Calls Change
+$18M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$137M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$215M
3
Victory Capital Management
3
Victory Capital Management
Texas
$57.5M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$37.7M
5
ACA
5
Avoro Capital Advisors
New York
$30.5M

Top Sellers

1
SCM
1
Sarissa Capital Management
Connecticut
$22.6M
2
HM
2
HealthCor Management
New York
$3.72M
3
SI
3
Sofinnova Investments
California
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$3.24M
5
BCPEMI
5
Bain Capital Public Equity Management II
Massachusetts
$8.46M
Name Market Value Shares Shares
Change 		Shares
Change %
IBT
26
International Biotechnology Trust
United Kingdom
$19.3M 57,000 +57,000 New
Marshall Wace
27
Marshall Wace
United Kingdom
$17.7M 1,085,846 +1,085,846 New
DM
28
Deerfield Management
New York
$16.5M 1,012,000 -674,140 -40%
SBH
29
Segall Bryant & Hamill
Illinois
$15.3M 943,792 +943,792 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$14.5M 892,108 +34,176 +4%
Norges Bank
31
Norges Bank
Norway
$12.9M 795,528 +77,854 +11%
Bank of America
32
Bank of America
North Carolina
$12M 736,441 +379,757 +106%
Morgan Stanley
33
Morgan Stanley
New York
$11.5M 710,047 +333,678 +89%
LCG
34
Lisanti Capital Growth
New York
$10.8M 662,644 +662,644 New
MB
35
MPM BioImpact
Massachusetts
$10.4M 639,089 -22,862 -3%
Osaic Holdings
36
Osaic Holdings
Arizona
$9.34M 574,249 +13,750 +2%
BCPEMI
37
Bain Capital Public Equity Management II
Massachusetts
$8.46M 520,199 -907,178 -64%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$8.44M 519,050 -613,215 -54%
PHP
39
Parkman Healthcare Partners
Connecticut
$7.76M 476,978 +76,977 +19%
GIM
40
Granahan Investment Management
Massachusetts
$7.63M 469,430 -661,148 -58%
Citadel Advisors
41
Citadel Advisors
Florida
$7.3M 449,156 +50,783 +13%
NSIM
42
North Star Investment Management
Illinois
$7.21M 443,400 -6,400 -1%
Swiss National Bank
43
Swiss National Bank
Switzerland
$6.92M 425,468 +32,900 +8%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$6.56M 403,195 +208,200 +107%
PAM
45
Panagora Asset Management
Massachusetts
$6.37M 392,008 +64,476 +20%
GTC
46
Ghost Tree Capital
New York
$5.69M 350,000 +350,000 New
GGHC
47
Gilder Gagnon Howe & Co
New York
$5.51M 339,009 -1,770 -0.5%
Rafferty Asset Management
48
Rafferty Asset Management
New York
$5.39M 331,713 -120,924 -27%
Allianz Asset Management
49
Allianz Asset Management
Germany
$4.96M 305,179 +42,064 +16%
Squarepoint
50
Squarepoint
New York
$4.93M 303,008 +254,642 +526%
1
2
3 4 5